Eric Paul Lefkofsky on American billionaire and entrepreneur managed to help cofound several businesses in particular Groupon as well as Tempus. He has recently turned his attention towards the tackling of cancer. Since 2015 with the help of the company he created Tempus Labs he has searched for a way to improve the diagnosis of cancer patients he has used data by gathering cleaning and organizing the large volume of patient data company has been able to personalize care for optimal cancer therapy and treatment.
This is not the start of Eric’s philanthropic endeavors as in 2006 he along with his wife founded a charitable trust known as the Lefkofsky Foundation which had the aim to support charitable scientific and educational organizations around the world with a particular emphasis on children. Today this organization has labeled the funding of over 50 organizations.
He is currently the Chief Executive Officer of Tempus a technology company which has a focus on the collection and elevation of molecular and clinical data. With the goals of enhancing precision medicine, the company has managed to create what are called data pipelines which help to collect cleanse and analyze data. When asked what the inspiration for the creation of this biotechnology company was Eric stated that someone who he cared for being afflicted by cancer was the impetus for the company.
The company has been able to collaborate with numerous hospital such as the Cleveland Clinic, Duke University school of medicine, Mayo Clinic, the University of Chicago medicine as well as countless local hospitals around the nation. As of September 2017 company has been able to raise over $130 million after a round of venture funding and the company was valued at over $700 million.
This is not the only company that Eric has founded he has founded the other global Internet commerce marketplace platform known as Groupon. In addition to these entrepreneurial endeavors, Eric has also held positions as a teacher at Kellstadt graduate school of business at Depaul University. Currently, he is serving as an adjunct professor at the University of Chicago’s Booth school of business where he helps many people in their entrepreneurial dreams.
Eric Lefkofsky’s Facebook Page: www.facebook.com/eplefkofsky/
What’s a man’s best approach to fighting prostate cancer, radiation or surgery? In a recent publication in the Huffington Post, Dr David Samadi utilized the recent successful surgical procedure to remove Mitt Romney’s prostate cancer and how he goes about discussing which of the two procedures are best for each individuals circumstances.
In the article Dr Samadi, a well known and respected oncologist/urologist, explains in detail what factors should be considered in determining whether radiation treatment or surgery is the best approach for his patients and why most of the time he will recommend surgery over radiation.
In short, if the tumor is discovered within the prostate gland then surgery is certainly the best option according to Dr Samadi, as statistics have proven that men that opt for radiation treatment to attack the prostate cancer are one and a half more times likely to die than those who opt for surgery.
Dr Samadi goes on to explain that if the cancer comes back after radiation treatments it can be very difficult to perform surgery after radiation and that in some cases the radiation can cause secondary cancers to form in other areas of the body as a result of the side effects from the treatment. He is using Mitt Romney’s recent successful surgery as a platform to present his medical expertise on the subject as well as other recent famous politicians who have successfully been through prostate cancer and opted for surgery over radiation, such as Colin Powell and John Kerry.
Dr David Samadi was born and raised in a Persian Jewish community. In 1979 following the Iranian Revolution Samadi left the country, after short stops in London and Belgium he landed in Roslyn, New York and after completing high school went on to study at Stony Brook University where he received his bachelor’s degree in biochemistry and remained at the university to complete his medical school studies. He then went on to his first postgraduate studies at Montefiore Medical Center and Albert Einstein College of Medicine.
Dr Samadi’s career has since been focused on oncology and urology. His research, studies and efforts have made him a leader in the fields at several New York City hospitals and facilities. In 2012 he was the highest paid doctor in New York City earning a reported $7.6 million dollars for his work. Samadi is a member of the American Urological Association and the American Medical Association.
Learn More: www.healthgrades.com/physician/dr-david-samadi-337fr